Physician profile
Eric N Bialaski
NPI 1144509274
$2,826.70
in general payments reported to CMS, 2019-2025
10 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.98 · 2020: $1,011 · 2021: $781 · 2022: $145 · 2023: $380 · 2024: $273 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $900.90 | 2020 | |
| Stryker Corporation | $850.85 | 2020-2022 | |
| Medtronic, INC. | $676.57 | 2022-2025 | Unid_pass, Stealthstation S8 Platform, Infinity Occipitocervical Upper Thoracic System |
| Biocomposites INC | $124.92 | 2025 | Stimulan |
| Globus Medical, INC. | $93.82 | 2020-2025 | Xlif, Cohere, Excelsiusgps Robotic Navigation System |
| Medtronic USA, INC. | $82.23 | 2019-2020 | |
| Nuvasive, INC. | $28.07 | 2019 | |
| Ucb, INC. | $26.70 | 2019 | |
| Octapharma USA, INC. | $25.84 | 2024 | Balfaxar |
| Upsher-Smith Laboratories LLC | $16.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bialaski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.